AKT1 and lip and oral cavity carcinoma: Thus, the miR-210-3p-EphrinA3-PI3K/AKT signaling axis is crucial in the progression of OSCC, indicating ephrinA3 as a promising target for oral cancer treatment (32) (Figure 1).